Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 22;12:8773–8785. doi: 10.2147/CMAR.S260537

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-106b-5p directly targets FJX1 and suppresses FJX1 expression. (A) The potential binding site between FJX1 and miR-106b-5p were exhibited. (B and C) Luciferase reporter assay was performed to demonstrate the relationship between FJX1 and miR-106b-5p in HCT116 and HT29 cells, respectively. (D–F) The relative level of FJX1 mRNA and protein were measured using qRT-PCR or Western blot assay in HCT116 and HT29 cells transfected with miR-NC, miR-106b-5p, anti-miR-NC or anti-miR-106b-5p. (G) The correlation between miR-106b-5p and FJX1 expression was analyzed using Pearson’s correlation analysis. *P<0.05.